III. Role of Anti-Angiogenesis Therapy for Advanced Non-Small Cell Lung Cancer - Current Status and Future Challenges
Hirai, F.
Gan to Kagaku Ryoho. Cancer and ChemoTherapy 42(8): 940-943
2015
ISSN/ISBN: 0385-0684 PMID: 26353391 Document Number: 680079
Document emailed within 1 workday
Related Documents
Shima, T.; Masai, K.; Hishida, T.; Kaseda, K.; Hashimoto, K.; Takahashi, Y.; Otsuka, T.; Asamura, H. 2018: Role of Surgery in Multimodality Treatment for Non-small Cell Lung Cancer;Current Status and Future Perspectives Kyobu Geka. Japanese Journal of Thoracic Surgery 71(4): 244-248Khuri, F.R. 2002: Docetaxel for locally advanced or metastatic non-small-cell lung cancer. Current data and future directions as front-line therapy Oncology 16(6 Suppl 6: 53-62
Pathak, A.K.; Bhutani, M.; Mohan, A.; Guleria, R.; Bal, S.; Kochupillai, V. 2004: Non small cell lung cancer (NSCLC): current status and future prospects Indian Journal of Chest Diseases and Allied Sciences 46(3): 191-203
Lind, J.S.W.; Herder, G.J.M.; Smit, E.F. 2008: New therapies for the treatment of advanced non-small cell lung cancer: inhibitors of the epidermal growth factor receptor and angiogenesis Nederlands Tijdschrift Voor Geneeskunde 152(16): 928-932
Yamaguchi, M.; Fukuyama, Y.; Ichinose, Y. 2003: Current status of the neo-adjuvant and adjuvant therapy for the resectable non-small cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 30(2): 203-208
Kaneko, K. 2013: Present status of extended resection for advanced non-small cell lung cancer Nihon Geka Gakkai Zasshi 114(4): 172
Ying Geng, Z.; Chang Jiao, S.; Cui Liu, S.; Li, Y.; Feng Liu, Z.; Qing Zhang, G.; Jie Wang, L.; Qu, F. 2013: Third-line therapy in advanced non-small cell lung cancer Journal of Buon: Official Journal of the Balkan Union of Oncology 18(4): 899-907
Tanović, A.; Alfaro, V. 2004: Gefitinib: current status in the treatment of non-small cell lung cancer Drugs of Today 40(10): 809-827
Perry, M.C. 1997: Future directions in the therapy of small cell lung cancer Chest Surgery Clinics of North America 7(1): 183-194
Nishimura, M.; Sugiura, T.; Urata, A.; Ota, K. 1985: Current status in the treatment of inoperable non-small cell lung cancer (NSCLC) Gan to Kagaku Ryoho. Cancer and ChemoTherapy 12(1): 54-60
Socinski, M.A. 1999: The current status of adjuvant chemotherapy for resected non-small cell lung cancer Seminars in Oncology 26(5 Suppl 15: 27-33
Kobyakov, D.S.; Avdalyan, A.M.; Lazarev, A.F.; Lushnikova, Y.L.; Nepomnyashikh, L.M. 2015: The Processes of cell Proliferation, Apoptosis and Angiogenesis in Pathologically Unchanged Lung and in Non-Small cell Lung Cancer Morfologiia 148(5): 65-70
Bunn, P.A. 1996: Current therapy of small cell lung cancer Seminars in Oncology 23(6 Suppl 16): 1-4
Hashizume, T.; Ogura, T.; Kozawa, S.; Kobayashi, N.; Tagawa, A.; Miyazawa, N.; Watanuki, Y.; Takahashi, H. 2006: Gefitinib as a first-line therapy in patients with advanced non-small cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 33(4): 467-470
Stokkel, M.P.; Kwa, B.M.; Pauwels, E.K. 1995: Imaging and staging of small-cell lung cancer: is there a future role for octreotide scintigraphy? British Journal of Clinical Practice 49(5): 235-238
Li, F.; Chen, G.; Jiao, S. 2015: Bevacizumab Combined with Chemotherapy as First-line Therapy for Advanced Non-Small Cell Lung Cancer: A Retrospective Study Hepato-Gastroenterology 62(140): 797-801
Morihata, K.; Kimura, M.; Okada, K.; Usami, E.; Nakao, T.; Yoshimura, T.; Hayase, K.; Yasuda, T. 2010: Comparative safety evaluation of first- and second-line therapy with carboplatin + paclitaxel for advanced non-small cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(1): 45-50
Eagan, R.T.; Lee, R.E.; Frytak, S.; Scott, M.; Ingle, J.N.; Creagan, E.T.; Nichols, W.C. 1981: Thoracic radiation therapy and Adriamycin/cisplatin-containing chemotherapy for locally advanced non-small-cell lung cancer Cancer Clinical Trials 4(4): 381-388
Mencoboni, M.; Bergaglio, M.; Serra, M.; Ivaldi, G.P.; Tredici, S.; Racchi, O.; Rebella, L.; Galbusera, V.; Grosso, M.; Faravelli, B. 2007: Maintenance therapy with gefitinib after first-line chemotherapy in patients affected by advanced non-small cell lung cancer Anticancer Research 27(6c): 4425-4429
Zhang, X.; Sun, Y.; Kong, W. 1998: Navelbine plus cisplatin combination therapy in the treatment of advanced non-small cell lung cancer: a report of 42 cases Zhonghua Zhong Liu Za Zhi 20(1): 60-62